NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.05% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.84% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 1.48% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.40% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.39% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 1.38% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.36% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.36% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.33% |
| GRAL | GRAIL, LLC | Healthcare | Diagnostics & Research | 1.29% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 1.28% |
| APGE | Apogee Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | 1.27% |
| CDTX | Cidara Therapeutics Inc | Healthcare | Biotechnology | 1.24% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 1.23% |
| RNA | Atrium Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | 1.22% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 1.22% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 1.22% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 1.21% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 1.21% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.20% |